Dra. María Natalia Gandur Quiroga (@nataliagandur) 's Twitter Profile
Dra. María Natalia Gandur Quiroga

@nataliagandur

Leader GU @InstitutoRoffo #GU #RCC #prostate #bladder #testis #GUcsm #clinicaltrials #Immunotherapy #PrecisionMedicine #OncoAlert #OncoReporte
Views Mine

ID: 1001912023750529024

calendar_today30-05-2018 19:43:35

5,5K Tweet

2,2K Takipçi

981 Takip Edilen

Dra. María Natalia Gandur Quiroga (@nataliagandur) 's Twitter Profile Photo
Dra. María Natalia Gandur Quiroga
@nataliagandur

24 days ago

🚨 Breaking News from Europe! 🚨 💫🌟European Commission Approves Astellas’ PADCEV™ (enfortumab vedotin) in Combination with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Advanced Urothelial Cancer🌟💫 OncoAlert World Bladder Cancer Patient Coalition Bladder Cancer Bladder Cancer Advocacy Network 🔹

🚨 Breaking News from Europe! 🚨 💫🌟European Commission Approves Astellas’ PADCEV™ (enfortumab vedotin) in Combination with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Advanced Urothelial Cancer🌟💫 <a href="/OncoAlert/">OncoAlert</a> <a href="/WorldBladderCan/">World Bladder Cancer Patient Coalition</a> <a href="/BladderCaJrnl/">Bladder Cancer</a> <a href="/BladderCancerUS/">Bladder Cancer Advocacy Network</a> 🔹